Loading company…
Mesosil develops antimicrobial biomaterials for medical devices.
Founded in 2018, Mesosil develops antimicrobial materials intended to prevent infection where medical devices meet tissue. Its technology is designed for dental restoratives and implant surfaces without changing clinician workflows. Based in Toronto, Canada, it raised CAD 2.2 million in Seed funding in June 2024, led by GreenSky Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in